XVIVO Perfusion AB: XVIVO Granted Breakthrough Device Design

GOTHENBURG, SE / ACCESSWIRE / September 20, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)

Related Keywords

China , Italy , Sweden , United States , Gothenburg , Vastra Gotalands Lan , Brazil , Kristoffer Nordstr , Breakthrough Devices Program , Centers For Medicare , Breakthrough Device Program , Drug Administration , Medicaid Services , Nasdaq , Breakthrough Device Designation , Liver Assist , Device Program , New England Journal , Dag Anderson , Xvivo , Erfusion , Granted , Breakthrough , Device , Resignation , Rom , Liver , Bassist ,